DAP:ETR
Danaher Corp
209,90 €
arrow_downward
-0,33%(-0,70) 1 d.
17. 11., 17:30:00 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre DAP…
Otvoriť
208,60 €
Vysoká
209,90 €
Nízka
207,70 €
Trh. kap.
158,84 mld.
Priem. obj.
520,00
Objem
410,00
Max. za 52 týž.
214,50 €
Min. za 52 týž.
138,20 €
Počet zamestnancov
59 tis.
Otvoriť
208,60 €
Vysoká
209,90 €
Nízka
207,70 €
Trh. kap.
158,84 mld.
Priem. obj.
520,00
Objem
410,00
Max. za 52 týž.
214,50 €
Min. za 52 týž.
138,20 €
Počet zamestnancov
59 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Investing.com
·
pred 11 hodinami
Danaher at Jefferies Global Healthcare Conference: growth plan takes shape
Profil
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Informácie o subjekte Danaher Corp
Generálny riaditeľRainer M. Blair
Zamestnanci59 tis.
Dátum založenia1969
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-
Webdanaher.com